Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
ad [2024/03/11 03:43] – [Alzheimer's Disease and Mild Cognitive Impairment] sflitmanad [2024/10/14 00:27] (current) – [Alzheimer's Disease and Mild Cognitive Impairment] sflitman
Line 4: Line 4:
  
 ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^ ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^
-| MCI and Mild AD |  Anti-Tau Oligonucleotide Spinal Injection   II  |  Yes  |  33%  |  54 weeks  |  Anticipated  |  +| MCI and Mild AD |  Anti-Tau Vaccine   II  |  Yes  |  33%  |  54 weeks  |  Anticipated  |  
-Agitation in Mild to Moderate AD |  Similar to Nuedexta  |  III   Yes  |  50%  |  12 weeks  |  No  | +MCI and Mild AD |  Anti-Tau Intravenous Antibody  |  II   Yes  |  50%  |  12 weeks  |  No  | 
  
 Also see [[imaging|Imaging]]. Also see [[imaging|Imaging]].
Print/export
QR Code
QR Code ad (generated for current page)